News

Oral semaglutide (Rybelsus) can be tied to a near halving of incident Afib, according to a meta-analysis of 26 randomized ...
Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...
Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at the Heart Rhythm ...
The biggest names in cardiac care gathered in San Diego for the Heart Rhythm Society (HRS) 2025 Annual Meeting.
Though women have a lower risk of ventricular arrhythmias than do men, it still exceeds the threshold to justify a device.
Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...
The US guidelines are likely to change following the release of the VANISH2 results last year, Christine Albert anticipates.
Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...
At least 26 million people worldwide have congestive heart failure, and heart failure itself is the leading cause of death ...
HeartBeam (Nasdaq:BEAT) today announced that a study of its synthesized 12-lead electrocardiogram (ECG) met its clinical ...
the annual meeting of the Heart Rhythm Society (HRS), held April 24–27 in San Diego. The abstract, titled “Real-world Experience with a Novel Wearable Cardioverter Defibrillator in a Community ...